Tauroursodeoxycholic acid

Tauroursodeoxycholic acid is a lipid of Sterol Lipids (ST) class. Tauroursodeoxycholic acid is associated with abnormalities such as Hyperglycemia, Obesity, Wiskott-Aldrich Syndrome, neurogenic hypertension and Cholestatic liver disease. The involved functions are known as Cell Death, Apoptosis, Homeostasis, Process and mRNA Expression. Tauroursodeoxycholic acid often locates in Body tissue, Endoplasmic Reticulum, Hepatic, Blood and Protoplasm. The associated genes with Tauroursodeoxycholic acid are Homologous Gene and Mutant Proteins. The related lipids are cholanic acid, taurolithocholic acid 3-sulfate, Sterols, 7-dehydrocholesterol and tauromuricholic acid. The related experimental models are Disease model.

Cross Reference

Introduction

To understand associated biological information of Tauroursodeoxycholic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Tauroursodeoxycholic acid?

Tauroursodeoxycholic acid is suspected in Endothelial dysfunction, Hyperglycemia, Obesity, neurogenic hypertension, Cholestatic liver disease, Heart failure and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Tauroursodeoxycholic acid

MeSH term MeSH ID Detail
Hypertension D006973 115 associated lipids
Insulin Resistance D007333 99 associated lipids
Total 2

PubChem Associated disorders and diseases

What pathways are associated with Tauroursodeoxycholic acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Tauroursodeoxycholic acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Tauroursodeoxycholic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Tauroursodeoxycholic acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Tauroursodeoxycholic acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Tauroursodeoxycholic acid?

Disease model

Disease model are used in the study 'Bile Acids Reduce Prion Conversion, Reduce Neuronal Loss, and Prolong Male Survival in Models of Prion Disease.' (Cortez LM et al., 2015).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Tauroursodeoxycholic acid

Download all related citations
Per page 10 20 50 100 | Total 531
Authors Title Published Journal PubMed Link
Setchell KD et al. Bile acid concentrations in human and rat liver tissue and in hepatocyte nuclei. 1997 Gastroenterology pmid:8978363
Gilani SS et al. Use of 1H NMR spectroscopy (T2 relaxation times) to examine the effects of conjugated ursodeoxycholic acid on phospholipid fluidity of human gallbladder bile. 1997 Biochem. Soc. Trans. pmid:9056921
Arrese M et al. Adaptive regulation of hepatic bile salt transport: role of bile salt hydrophobicity and microtubule-dependent vesicular pathway. 1997 J. Hepatol. pmid:9075679
Takikawa H et al. Effect of tauro-alpha-muricholate and tauro-beta-muricholate on oestradiol-17 beta-glucuronide-induced cholestasis in rats. 1997 J. Gastroenterol. Hepatol. pmid:9076630
Larghi A et al. Ursodeoxycholic and tauro-ursodeoxycholic acids for the treatment of primary biliary cirrhosis: a pilot crossover study. 1997 Aliment. Pharmacol. Ther. pmid:9146783
van Nieuwerk CM et al. The role of bile salt composition in liver pathology of mdr2 (-/-) mice: differences between males and females. 1997 J. Hepatol. pmid:9148004
Luk AS et al. Structural mechanisms of bile salt-induced growth of small unilamellar cholesterol-lecithin vesicles. 1997 Biochemistry pmid:9153403
Loria P et al. Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans. 1997 Hepatology pmid:9185744
van de Heijning BJ et al. Membrane cholesterol content of cholesterol/phospholipid vesicles determines the susceptibility to both damage and protection by bile salts: implications for bile physiology. 1997 Eur J Gastroenterol Hepatol pmid:9187880
Crocenzi FA et al. Role of bile salts in colchicine-induced hepatotoxicity. Implications for hepatocellular integrity and function. 1997 Toxicology pmid:9230445
Balandraud-Pieri N et al. Effects of tauroursodeoxycholate solutions on cyclosporin A bioavailability in rats. 1997 Drug Metab. Dispos. pmid:9280397
Ishizaki K et al. Effect of sodium tauroursodeoxycholate (UR-906) on liver dysfunction in bile duct-ligated rats. 1997 Eur. J. Pharmacol. pmid:9314037
Schliess F et al. Mitogen-activated protein kinases mediate the stimulation of bile acid secretion by tauroursodeoxycholate in rat liver. 1997 Gastroenterology pmid:9322526
Meier PJ et al. Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver. 1997 Hepatology pmid:9398014
Rao YP et al. Activation of protein kinase C alpha and delta by bile acids: correlation with bile acid structure and diacylglycerol formation. 1997 J. Lipid Res. pmid:9458268
Roda A et al. Taurohyodeoxycholic acid protects against taurochenodeoxycholic acid-induced cholestasis in the rat. 1998 Hepatology pmid:9462652
Schroeder A et al. Substrate specificity of the rat liver Na(+)-bile salt cotransporter in Xenopus laevis oocytes and in CHO cells. 1998 Am. J. Physiol. pmid:9486191
Takikawa H et al. Absorption of unconjugated bile acids and tauroursodeoxycholate in the rat intestine. 1997 J. Gastroenterol. Hepatol. pmid:9504891
Vendemiale G et al. Ethanol-induced changes of intracellular thiol compartmentation and protein redox status in the rat liver: effect of tauroursodeoxycholate. 1998 J. Hepatol. pmid:9537863
Benz C et al. Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis and cytolysis in rat hepatocytes. 1998 J. Hepatol. pmid:9537871
Klinkspoor JH et al. Bile salts stimulate mucin secretion by cultured dog gallbladder epithelial cells independent of their detergent effect. 1998 Biochem. J. pmid:9576876
Beuers U Effects of bile acids on hepatocellular signaling and secretion. 1997 Jul-Aug Yale J Biol Med pmid:9626754
Sreejayan N and von Ritter C Effect of bile acids on lipid peroxidation: the role of iron. 1998 Free Radic. Biol. Med. pmid:9655521
Bouscarel B et al. Changes in G protein expression account for impaired modulation of hepatic cAMP formation after BDL. 1998 Am. J. Physiol. pmid:9696716
Benz C et al. Effect of S-adenosylmethionine versus tauroursodeoxycholic acid on bile acid-induced apoptosis and cytolysis in rat hepatocytes. 1998 Eur. J. Clin. Invest. pmid:9726039
Yamaguchi Y et al. Taurin-conjugated ursodeoxycholic acid has a reversible inhibitory effect on human keratinocyte growth. 1998 J. Dermatol. Sci. pmid:9747660
Peterson TC et al. The inhibitory effect of ursodeoxycholic acid and pentoxifylline on platelet derived growth factor-stimulated proliferation is distinct from an effect by cyclic AMP. 1998 Immunopharmacology pmid:9754904
Ono T et al. Tauroursodeoxycholic acid protects cholestasis in rat reperfused livers: its roles in hepatic calcium mobilization. 1998 Dig. Dis. Sci. pmid:9790455
Invernizzi P et al. Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis. 1999 Hepatology pmid:9918905
Milkiewicz P et al. Tauroursodeoxycholate and S-adenosyl-L-methionine exert an additive ameliorating effect on taurolithocholate-induced cholestasis: a study in isolated rat hepatocyte couplets. 1999 Hepatology pmid:9918924
Miyake H et al. Partial characterization of mechanisms of cytoprotective action of hydrophilic bile salts against hydrophobic bile salts in rats: relation to canalicular membrane fluidity and packing density. 1999 Dig. Dis. Sci. pmid:9952244